-
31 July 2025 23:25:06
- Source: Sharecast

31 July 2025
SABRE INSURANCE GROUP PLC
Appointment of Non-executive Director
Sabre Insurance Group plc (the "Group" or "Sabre") is pleased to announce the appointment to the Board of David Neave as a Non-executive Director, with effect from 1 August 2025. On appointment, David will join Sabre's Audit and Remuneration Committees.
David is a seasoned insurance professional with extensive experience in the UK general insurance industry, spanning executive, non-executive and advisory roles. David served as the CEO at Co-operative Insurance between 2005 and 2013, where he led transformation and technology initiatives. Prior to that, he spent twenty-five years in various positions at Royal Insurance/RSA, where he finished as the Claims Service Director for UK Claims. More recently, David has served as a Non-executive Director on the Board of Direct Line Insurance Group plc and has held non-executive positions at the insurer LV= (and Chair of their General Insurance Board), Slater and Gordon UK Limited (where he chaired the Audit and Risk Committee), and Solicitors' Indemnity Fund. He has also held advisory roles at Accenture UK, the Insurance Fraud Bureau and the Association of British Insurers. David is currently the Chair of the Advisory Board at CAPS and is a Fellow of the Chartered Insurance Institute.
Rebecca Shelley, Sabre's Chair, commented:
"David's extensive insurance knowledge and experience will add significant value to Sabre, as we continue to work towards achieving our Ambition 2030 objectives. I am delighted to welcome him to the Board and look forward to working with him."
Pursuant to Listing Rule 9.6.13R, it is confirmed there are no other disclosures required in addition to the above information.
Enquiries |
|
Teneo James Macey White Ffion Dash |
020 7353 4200 sabre@teneo.com
|
LEI Code: 2138006RXRQ8P8VKGV98
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.